Partial splenic embolization is a common procedure that reduces thrombocytopenia in
patients with hypersplenism. The present review evaluated the adverse event profile of …

Esophagogastric variceal bleeding (EGVB) is one of the main complications of portal
hypertension, especially in patients with liver cirrhosis, and has a very high fatality rate. At …

Background Global research on endoscopic therapies in combination with partial splenic
embolization (PSE) for variceal hemorrhage (VH) is limited. Therefore, we aimed to evaluate …

Background This study aimed to compare the efficacy of partial splenic embolization (PSE)
combined with endoscopic therapy and endoscopic therapy alone in cirrhosis patients with …

Purpose The aim of this study was to investigate the efficacy and safety of the combination of
low-molecular-weight heparin+ dexamethasone after partial splenic embolization in cirrhotic …

Objective This study primarily aimed to investigate the short-term effects of partial splenic
embolization (PSE) on the Child-Pugh score and identify predictive factors for changes in …

Background Primary hepatocellular carcinoma is often complicated with hepatitis and liver
cirrhosis. Some patients develop different degrees of splenomegaly, hypersplenism and …

Objective: To observe the immediate and mid-term effects of partial spleen embolization
(PSE) in reducing hepatic venous pressure gradient (HVPG) in patients with cirrhotic …

This study describes a case of hepatitis C virus‐related decompensated cirrhosis with portal‐
systemic liver failure and refractory encephalopathy. It was successfully managed with a …

BACKGROUND Partial splenic embolization (PSE) has been suggested as an alternative to
splenectomy in the treatment of hypersplenism. However, some patients may experience …